The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data
- 1 October 2008
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 35 (5) , 503-526
- https://doi.org/10.1007/s10928-008-9099-z
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosingBritish Journal of Clinical Pharmacology, 2000
- Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilideBritish Journal of Clinical Pharmacology, 2000
- Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trialAmerican Heart Journal, 1999
- Pharmacodynamics and Pharmacokinetics of the Class III Antiarrhythmic Agent Dofetilide (UK-68,798) in HumansJournal of Cardiovascular Pharmacology, 1993
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1992
- Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassayJournal of Pharmaceutical and Biomedical Analysis, 1991
- A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolamJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976